PT001 MDI

· Pearl Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PT001 MDI, covering 2017-06-08 to 2017-10-12. Get the full timeline:

Most recent: Clinical Trial Update: PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD [Phase 2]